Pneumonitis and acute lung inflammation studies demand faultless models.

Acute Lung Inflammation (ALI) and Acute Respiratory Distress Syndrome (ARDS) initiate and propagate lung injury through a plethora of mechanisms which until today, after more than 35 years of research, still aren’t fully understood. And while human studies have provided scientists with critical descriptive data on the development and pathophysiology of inflammatory processes in the lungs, the need for animal models to understand the mechanism of injury at the biochemical level grows only more relevant as time passes. 

At PharmaLegacy, we understand the ever-growing need for state-of-the-art animal models in ALI and ARDS. With our Lipopolysaccharide-induced ALI models in mice, rats and monkeys, we are committed to providing you with everything you need to take your preclinical studies all the way to the finish line.

Contact Us
Pneumonitis / Acute Lung Inflammation


Pioneering Healthcare Solutions:

  • Capacity to house over 30,000 rodents and large animals
  • On-site capacity for up to 350 non-human primates, with off-site capacity for up to 30,000 Cynomolgus and Rhesus monkeys
  • Operations and IT structured for maximum protection of clients’ data and IP
  • 24/7 access to PharmaLegacy representatives

Commit to a CRO that can meet your expectations, and more. Work with PharmaLegacy.

Contact Us

We’re ready when you are.

Tell us your pharmacology challenges.